Severe ischemic bowel necrosis caused by terlipressin during treatment of hepatorenal syndrome
Terlipressin is a vasopressin analogue that is widely used in the treatment of hepatorenal syndrome or variceal bleeding. Because it acts mainly on splanchnic vessels, terlipressin has a lower incidence of severe ischemic complications than does vasopressin. However, it can still lead to serious com...
Main Authors: | Hae Rim Kim, Young Sun Lee, Hyung Joon Yim, Hyun Joo Lee, Ja Young Ryu, Hyun Jung Lee, Eileen L. Yoon, Sun Jae Lee, Jong Jin Hyun, Sung Woo Jung, Ja Seol Koo, Rok Sun Choung, Sang Woo Lee, Jai Hyun Choi |
---|---|
Format: | Article |
Language: | English |
Published: |
Korean Association for the Study of the Liver
2013-12-01
|
Series: | Clinical and Molecular Hepatology |
Subjects: | |
Online Access: | http://e-cmh.org/upload/pdf/cmh-19-417.pdf |
Similar Items
-
Terlipressin effect on hepatorenal syndrome: Updated meta‐analysis of randomized controlled trials
by: Mohamed M G Mohamed, et al.
Published: (2021-08-01) -
Low doses of terlipressin and albumin in the type I hepatorenal syndrome
by: Davide Pulvirenti, et al.
Published: (2013-05-01) -
Terlipressin for the Prevention and Treatment of Renal Decline in Hepatorenal Syndrome: A Drug Profile
by: Ahlam Ayyad, et al.
Published: (2023-09-01) -
Hepatorenal syndrome: Current concepts and future perspectives
by: Chan-Young Jung, et al.
Published: (2023-10-01) -
A case of peripheral gangrene and osteomyelitis secondary to terlipressin therapy in advanced liver disease
by: Heon Ju Lee, et al.
Published: (2013-06-01)